Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Yellow subthreshold micropulse laser (YSML) is a retinal laser capable of inducing a biologic response without causing thermal damage to the targeted tissue. The 577-nm YSML is delivered to the retina abiding by different protocols in which wavelength, power, duration, spot size and number of spots can be properly set to achieve the most effective and safe treatment response in various chorioretinal disorders. The ultrashort trains of power modulate the activation of the retinal pigment epithelium cells and intraretinal cells, such as Müller cells, causing no visible retinal scars. Subthreshold energy delivered by YSML stimulates the production of the heat-shock proteins, highly conserved molecules that protect cells against any sort of stress by blocking apoptotic and inflammatory pathways that cause cell damage. YSML treatment allows resorption of the subretinal fluid in central serous chorioretinopathy and intraretinal fluid in various conditions including diabetic macular edema, postoperative cystoid macular edema and other miscellaneous conditions. YSML also seems to modulate the development and progression of reticular pseudodrusen in dry age-related macular degeneration. The aim of this review is to discuss and summarize the safety and efficacy of YSML treatment in retinal diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164197PMC
http://dx.doi.org/10.1007/s40123-023-00698-wDOI Listing

Publication Analysis

Top Keywords

yellow subthreshold
8
subthreshold micropulse
8
micropulse laser
8
retinal diseases
8
ysml treatment
8
macular edema
8
ysml
6
retinal
5
laser retinal
4
diseases in-depth
4

Similar Publications

To report the results of Endpoint Management (EpM) with PASCAL laser in the treatment of chronic central serous retinopathy (CSR). A 577 nm yellow laser was applied using PASCAL with EpM to 11 eyes on 11 patients who were followed for CSR for at least 12 months in this prospective study. The laser spot size was set to 200 μm, the pulse duration was 15 msec, and the spot spacing was set to 0.

View Article and Find Full Text PDF

Comparative efficacy of subthreshold micropulse laser therapy for chronic central serous chorioretinopathy: Navigated vs. non-navigated approach.

J Fr Ophtalmol

May 2025

Department of Ophthalmology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Basaksehir Olympic Boulevard Road, Basaksehir, Istanbul, Turkey.

Purpose: To evaluate the efficacy of navigated subthreshold micropulse laser (NSML) compared to subthreshold micropulse laser (SML) without navigation in the management of chronic central serous chorioretinopathy (CSCR).

Materials And Methods: This retrospective study included patients diagnosed with chronic CSCR who underwent either NSML or SML without navigation. Patients meeting inclusion criteria presented with serous macular detachment and leakage at the level of the retinal pigment epithelium on fundus fluorescein angiography (FFA).

View Article and Find Full Text PDF

Purpose: To assess the safe, lowest effective laser power of subthreshold micropulse laser (SML) for treating acute and chronic central serous chorioretinopathy (CSC) in Chinese patients.

Methods: Patients were distinguished with acute or chronic CSC based on focal or diffuse retinal pigment epithelium (RPE) leakage on fundus fluorescein angiography (FFA), with or without widespread RPE decompensation. Patients were categorized into five groups and treated with 577 nm yellow SML according to 50% titration power.

View Article and Find Full Text PDF

Purpose: To assess the safety and efficacy of the yellow sub-threshold micropulse laser (YSML) in eyes with uveitic macula edema (UME).

Methods: A prospective interventional study. Eyes with non-infectious UME and an unsatisfactory response to prior conventional treatments underwent navigated YSML (NAVILAS).

View Article and Find Full Text PDF
Article Synopsis
  • * Conducted at Chongqing Aier Eye Hospital, the study included 24 participants with PSF for at least one month after surgery, who were randomized to receive either SML or sham treatment, with evaluations over six months for changes in fluid volume and visual acuity.
  • * Results showed a significant reduction in OCT volume around the macular fovea in the SML group compared to the sham group after six months, indicating that SML may help absorb
View Article and Find Full Text PDF